Indicators

Latest News about BCYC

Recent news which mentions BCYC

< Previous 1 2 3 Next >

B. Riley Securities Downgrades Rating to Neutral for Bicycle Therapeutics, Lowers Price Target To $33

April 13, 2022

Where Bicycle Therapeutics Stands With Analysts

April 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

April 13, 2022

Here's Why Bicycle Therapeutics Stock Looks Ill Today

April 11, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

April 11, 2022

The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More

April 10, 2022

Why Bicycle Therapeutics Stock Is Soaring Today

April 08, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

April 08, 2022

Bicycle Therapeutics's Return On Capital Employed Overview

March 04, 2022

What 4 Analyst Ratings Have To Say About Bicycle Therapeutics

March 03, 2022

Bicycle Therapeutics: Q4 Earnings Insights

March 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022

February 14, 2022

12 biotech stocks to consider buying now as prospects for the sector brighten this year

February 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021

December 17, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021

December 09, 2021

7 A-Rated Biotechs to Buy for the Long Run

December 03, 2021

Looking Into Bicycle Therapeutics's Return On Capital Employed

November 08, 2021

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

October 12, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

45 Biggest Movers From Yesterday

October 08, 2021

Bicycle Therapeutics Stock Falls After Interim Data Of Toxin Conjugates In Ovarian Cancer Trial

October 07, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session

October 06, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More

October 03, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021

September 30, 2021

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

September 17, 2021

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

September 16, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

September 10, 2021

Bicycle Therapeutics Earnings Perspective: Return On Capital Employed

September 08, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.